Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Co-developing immune-evasive allogeneic TCR-iPS-T-cell therapies for the treatment of solid tumors

Related Keywords

Kyoto ,Japan ,San Francisco ,California ,United States ,Sweden ,Dan Kemp ,Reagan Jarvis ,Shin Kaneko ,Tobias Deuse ,Linkedin ,Kyoto University ,University Of California ,Japani May ,Shinobi Therapeutics ,Allogeneic Cell ,